GLP1R and obesity due to melanocortin 4 receptor deficiency: GLP-1 receptor agonists, primarily utilized in the management of type 2 diabetes and obesity due to their significant effects on appetite control and weight management, especially semaglutide, a GLP-1 analog, have recently garnered widespread attention.